Support
[email protected]For account, sync, and launch access questions.
Use the form for launch access, integration questions, product feedback, or documentation gaps. Medical decisions should stay with licensed clinicians.
For account, sync, and launch access questions.
For product gaps, copy issues, and care-team workflow ideas.
For insulin-context or medical-boundary questions.
Common questions
No. GlucIQ organizes meal, glucose, and insulin context, but dosing decisions must follow your clinician-guided care plan.
No. Estimates are starting points. GlucIQ keeps them editable and clearly separate from treatment instructions.
Dexcom OAuth and FreeStyle Libre via LibreLinkUp have documented integration paths that are being validated for launch. Stelo, Lingo, Eversense, and health-platform sync are planned.
Yes. Manual glucose, meal, and insulin logging is a first-class path. The timeline works the same way.
Fat-Protein Units estimate the delayed glucose effect of fat and protein. Most consumer apps ignore it; GlucIQ includes it in the visible insulin math.
Manual logging keeps the record continuous while a connection is checked or restored.
GlucIQ begins with DE and US food context. Country-aware recognition expands from there; release availability will be published by region.
Generic trackers stop at macros. GlucIQ is designed around meal-to-glucose review for diabetes routines, with AI reasoning kept visible.